Effectiveness of short-term analytical group therapy on reducing craving, depression, anxiety and increasing quality of life in patients with substance use disorder with a history of hospitalization in the addiction department of Iran Psychiatric Hospital

Effectiveness of short-term analytical group therapy on reducing craving, depression, anxiety and increasing quality of life in patients with substance use disorder with a history of hospitalization

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20221126056615N2

Enrollment

Registered

2024-02-20

Start date

2024-02-29

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance use disorders. Other psychoactive substance related disorders

Interventions

Intervention 1: Intervention group: After taking the pre-test, this group will undergo 52 weekly sessions (according to the Foulkes Analytical Group Therapy protocol) under the supervision of the Anal

Eligibility

Sex/Gender

Male

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients with a history of hospitalization in the addiction department of a psychiatric hospital who have completed the initial course of withdrawal Patients who intend to be abstinent during a one-year period Patients are required to undergo drug treatment under the supervision of a psychiatrist History of drug use No drug use in the previous day

Exclusion criteria

Exclusion criteria: Substance-induced psychotic disorder Having intellectual disability Having cognitive disorders Having severe psychiatric disorders Attending the group in a state of drug intoxication Received electroconvulsive during the last 6 months Non-adherence to psychiatric drug treatments Failure to adhere to abstinence from substances in the past 48 hours

Design outcomes

Primary

Measure	Time frame
The level of craving. Timepoint: Before and after the intervention. Method of measurement: Obsessive Compulsive Drug Use Scale.;The level of depression. Timepoint: Before and after intervention. Method of measurement: Beck Depression Inventory.;The level of anxiety. Timepoint: Before and after intervention. Method of measurement: Beck Anxiety Inventory.;The level of quality of life. Timepoint: Before and after intervention. Method of measurement: World Health Organization Quality of Life Questionnaire.	—

Measure

Time frame

The level of craving. Timepoint: Before and after the intervention. Method of measurement: Obsessive Compulsive Drug Use Scale.;The level of depression. Timepoint: Before and after intervention. Method of measurement: Beck Depression Inventory.;The level of anxiety. Timepoint: Before and after intervention. Method of measurement: Beck Anxiety Inventory.;The level of quality of life. Timepoint: Before and after intervention. Method of measurement: World Health Organization Quality of Life Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNeda Vahed

Iran University of Medical Sciences

vahedneda@yahoo.com+98 21 4450 3395

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026